CVS Pages Conflict and Texas Screwworm Zones Change

1. CVS pages conflict on which stores fill pet prescriptions

OBSERVED

CVS Health announced on July 21, 2026, that common dog and cat prescription medicines were available at its approximately 9,000 CVS pharmacies nationwide. CVS said eligible pet prescriptions can use automatic refills and a service that aligns refill dates. Some medicines may also qualify for delivery. ¹

CVS currently directs owners to present a written prescription or ask their veterinarian to contact a CVS pharmacy. It plans to add electronic prescribing in the coming months. ²

At 6:00 AM ET July 23, 2026, CVS Pharmacy's pet medicine page still said pet prescriptions were being piloted in selected pharmacies. It also said the medicines shown were carried in selected stores. CVS has yet to publish participating stores, store level stock, prices, prescription fill counts or repeat refill rates. ²

VIEWPOINT

The conflicting pages could send prescription requests to stores without the service or requested medicine. Each unsuccessful request could add calls, prescription rerouting and client follow-up. Direct veterinarian contact may add staff work until electronic prescribing becomes available.

Broad availability across approximately 9,000 stores would add national pickup, refill and eligible delivery options. Completed prescriptions and repeat refills will show owner use. Clinics should verify local service before changing client guidance. Suppliers should compare their own orders and refills before revising forecasts.

CONFIDENCE

Moderate — Both pages are current CVS sources, and their store availability claims still conflict. CVS has yet to publish a participating store list or explanation.

ACTIONS

↑ Back to top

2. Texas adds 3 screwworm zones and replaces Zone 14 with Zone 14.A

OBSERVED

The executive director of the Texas Animal Health Commission signed 4 orders from July 15 to 21. The first 3 created New World screwworm Infested Zones 15, 16 and 17. Zone 15 covers a mapped part of Pecos County. ³ Zone 16 covers mapped parts of Starr and Zapata counties. ⁴ Zone 17 covers mapped parts of Schleicher and Sutton counties. ⁵

The July 14 order followed a canine detection in Sutton County. The July 21 order followed another detection there, this time in a goat. It replaced Zone 14 and designated mapped parts of Schleicher and Sutton counties as Zone 14.A. ⁶

Before a warm-blooded animal leaves any of the 4 zones, the person responsible must obtain commission authorization. The animal must be inspected, receive any required treatment and have a permit or certificate from a commission representative. Each order took effect immediately and remains in force until the commission releases its quarantine. ^{3, 4, 5, 6}

VIEWPOINT

The movement rule applies for dogs and cats when they start inside a mapped zone and travel outside it. Clinics need the starting address and destination before giving travel advice.

Zones 14.A and 17 are separate mapped areas within Schleicher and Sutton counties. A county name alone cannot show whether an address sits inside a zone. Zone 14.A also replaced an earlier order after another Sutton County detection. A saved map or checklist can therefore become outdated during the same week.

Each affected movement requires commission authorization, an inspection and a permit or certificate. Treatment may also apply. These steps could add owner calls and delay trips, rescue transfers or referrals. Suppliers need account level order changes before attributing demand changes to the zones.

CONFIDENCE

High — 4 signed commission orders provide mapped boundaries, dates and movement requirements. The Zone 14.A order confirms the additional Sutton County detection and replacement of Zone 14. Dog and cat movement volumes, issued certificates, owner calls and travel delays remain unreported.

ACTIONS

↑ Back to top

3. FDA pilot offers 2 review incentives for U.S. animal drug manufacturing

OBSERVED

The FDA launched a voluntary pilot on July 21 for companies seeking approval for new or generic animal drugs. ⁷

The first incentive covers a complete chemistry, manufacturing, and controls technical section. FDA may consider reviewing the section ahead of other submissions in its queue. The section describes the drug’s ingredients, manufacturing process and quality controls. The finished drug and every active ingredient must be manufactured in the U.S. ⁸

The second incentive lets a sponsor include 2 active ingredient sources in its original submission. FDA will review both sources when at least one is manufactured in the U.S. Including both sources at this stage can avoid a separate submission after approval. ^{7, 8}

FDA directs sponsors to discuss eligibility with its Division of Manufacturing Technologies before submitting. Participant names, products, review dates, full-application dates, production volumes and delivery results remain pending. ⁸

VIEWPOINT

The first incentive could move the manufacturing section forward in FDA’s review queue. FDA leaves the review duration open. The remaining application sections follow separate review paths. Sponsors need product-specific FDA dates before advancing launch or revenue plans.

The second incentive brings 2 active ingredient sources into the original review. Approval of both sources could give a sponsor another supplier during a shortage. The supply effect will depend on approved capacity, quality results and delivery performance.

Manufacturers have the immediate submission decision. Clinics, groups and distributors need a named companion animal product, FDA approval and measured production and shipment results before changing purchases.

CONFIDENCE

High — FDA’s pages define both incentives, their eligibility rules and the contact process. Named products, review dates, full-application dates, production and delivery results remain unpublished.

ACTIONS

↑ Back to top

4. Four Corners completes $268 million purchase of 102 Mission-operated veterinary properties

OBSERVED

Four Corners Property Trust completed its $268 million purchase of 102 properties operated by Mission Pet Health on July 16, 2026. Four Corners reported about $17.37 million in cash rent for the next 12 months. The filing also states that the transaction included a rent credit received at closing. ⁹

Shore Capital Partners said the transaction transferred the real estate while Mission retained the veterinary operations. Mission will remain the long-term tenant and clinic operator under net leases. ¹⁰

VIEWPOINT

Four Corners now owns the 102 properties, while Mission remains the tenant and clinic operator. The $268 million price and $17.37 million rent figure cover the full portfolio. Clinic level analysis requires property specific prices, rent and lease terms.

The sale changes property ownership while Mission continues operating the clinics. Suppliers should keep property ownership separate from purchasing contacts. Buyer records should change after Mission confirms a change. A value for Mission’s operating business requires separate evidence.

CONFIDENCE

High — Four Corners’ SEC filing confirms the closing, property count, purchase price, rent and Mission’s operating role. Shore confirms Mission remains the long-term tenant. Property level prices, rent and lease terms remain unpublished.

ACTIONS

↑ Back to top

5. Virbac reports companion animal revenue growth as total North American revenue falls

OBSERVED

Virbac reported €48 million in second quarter North American revenue. Revenue fell 0.8% after Virbac adjusted for currency movements and changes in the businesses included in the comparison. It fell 2.4% as reported. Companion animal revenue grew 9.1% after adjusting for currency movements only. ¹¹

Virbac combines its U.S. and Canadian operations in its North American results. ¹²

Virbac attributed companion animal growth to mobility, dental care and ear care products and Thyronorm. It linked the total regional decline to a temporary hold on products made under one manufacturing contract. Supply problems at a contract manufacturer also affected farm animal products. Virbac said production and sales under the affected contract resumed in July. ¹¹

First half North American revenue reached €103 million and rose 10.1% after currency and scope adjustments. Virbac said changes in distributor stock helped the result. Group first half revenue reached €768 million, up 7.4% on that basis. Thyronorm contributed 1.4 percentage points to the group’s first half growth. ¹¹

VIEWPOINT

The 9.1% companion animal increase and 0.8% total North American decline cover different product groups and use different adjustment methods. Virbac named growth categories, while category growth rates and product units remain unavailable.

Distributor stock movements can change manufacturer revenue before products reach clinics or pet owners. Customer orders, shipped units, back orders and stock can show current demand and July’s supply restart. U.S. operators should use those measures before changing forecasts.

CONFIDENCE

High — Virbac’s official unaudited release reports the figures and management’s explanation. U.S.-only results, product units, distributor sales to customers and customer demand remain unpublished.

ACTIONS

↑ Back to top